Holen Sie sich die Stockscreener-App
13.83
1.57%
-0.22
Vorhandelsmarkt:
14.00
0.17
+1.23%
Schlusskurs vom Vortag:
$14.05
Offen:
$14.02
24-Stunden-Volumen:
452.32K
Relative Volume:
1.67
Marktkapitalisierung:
$1.31B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-6.43%
1M Leistung:
-23.17%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$13.74
$14.02
1-Wochen-Bereich:
$13.74
$15.52
52-Wochen-Spanne:
$13.74
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
Firmenname
Lumexa Imaging Holdings Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie LMRI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
13.83 | 1.33B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Eingeleitet | Barclays | Overweight |
| 2026-01-05 | Eingeleitet | Deutsche Bank | Buy |
| 2026-01-05 | Eingeleitet | JP Morgan | Overweight |
| 2026-01-05 | Eingeleitet | Jefferies | Buy |
| 2026-01-05 | Eingeleitet | Leerink Partners | Outperform |
| 2026-01-05 | Eingeleitet | Raymond James | Outperform |
| 2026-01-05 | Eingeleitet | Wells Fargo | Overweight |
| 2026-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Lumexa Imaging Holdings Inc Aktie (LMRI) Neueste Nachrichten
Lumexa Imaging Holdings, Inc.’s Quiet Period Set To End on January 20th (NASDAQ:LMRI) - Defense World
FinancialContentLumexa Imaging Holdings, Inc.Common Stock (Nasdaq:LMRI) Stock Quote - FinancialContent
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March - Investing.com Nigeria
Lumexa Imaging Holdings, Inc. Announces Resignation of Chief Legal Officer and Corporate Secretary Julie Szeker, Effective March 13, 2026 - marketscreener.com
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March By Investing.com - Investing.com South Africa
Lumexa Imaging Announces Chief Legal Officer Resignation - TipRanks
Assessing Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Pullback - Yahoo Finance
LMRI: Global radiopharma leader drives growth with late-stage oncology pipeline and strategic expansion - TradingView — Track All Markets
Lumexa Imaging: Resilient Demand With Compounding Scale Moat (NASDAQ:LMRI) - Seeking Alpha
Lumexa Imaging Holdings, Inc.Common Stock (NQ: LMRI - FinancialContent
Lumexa Imaging Achieves Record De Novo Expansion in 2025 - Sahm
Lumexa Imaging Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Target Price Consensus and Analysts Recommendations | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Dividend historical data and projections - MarketScreener
Analysts Offer Insights on Technology Companies: Advanced Micro Devices (AMD) and Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Analysts Offer Insights on Technology Companies: Broadcom (AVGO), Lumexa Imaging Holdings, Inc. (LMRI) and Apple (AAPL) - The Globe and Mail
Lumexa Imaging Holdings: Leveraging Outpatient Growth and JV Model to Drive Premium-Valued Expansion and Deleveraging Upside - TipRanks
Lumexa Imaging Announces Participation in Upcoming January 2026 Investor Conference - BioSpace
Lumexa Imaging Announces Participation in Upcoming Investor Conf - GuruFocus
Lumexa Imaging Announces Participation in Upcoming Investor Conference - Finviz
Lumexa Imaging Holdings: Secular Tailwinds, High-Return Expansion, and Joint-Venture Model Support Buy Rating - TipRanks
Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO - One News Page
Deutsche Bank Initiates Lumexa Imaging at Buy With $22 Price Target - marketscreener.com
Deutsche Bank initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com Canada
JPMorgan Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Jefferies Initiates Lumexa Imaging at Buy With $23 Price Target - marketscreener.com
Barclays Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Leerink Partners Initiates Lumexa Imaging at Outperform With $23 Price Target - marketscreener.com
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
LMRI Archives - 24/7 Wall St.
Wells Fargo initiates Lumexa Imaging stock with Overweight rating By Investing.com - Investing.com Canada
Lumexa Imaging stock initiated with Outperform rating by William Blair - Investing.com
Lumexa Imaging Holdings: Capitalizing on Outpatient Imaging Tailwinds with Sustainable Growth and Attractive Risk-Reward - TipRanks
Raymond James initiates Lumexa Imaging stock with Outperform rating By Investing.com - Investing.com Canada
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Lumexa Imaging stock with Overweight rating, $23 target By Investing.com - Investing.com Canada
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com
Lumexa Imaging Holdings, Inc. (LMRI) - Zacks Investment Research
Lumexa Imaging refinances debts, fills out board of directors - Radiology Business
Lumexa Imaging Secures New Long-Term Senior Credit Facilities - TipRanks
Lumexa Imaging Signs Amended Credit Agreement With Barclays Bank - TradingView — Track All Markets
LUMEXA IMAGING HOLDINGS INC (LMRI) Stock Technical Analysis - Chartmill
Finanzdaten der Lumexa Imaging Holdings Inc-Aktie (LMRI)
Es liegen keine Finanzdaten für Lumexa Imaging Holdings Inc (LMRI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):